Johns Hopkins Psychiatry Guide
Selegiline
INDICATIONS
FDA
FDA
- Major depressive disorder (patch)
- Parkinson’s disease (adjunct) (oral)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Major depressive disorder (oral)
- Schizophrenia (adjunct) (oral)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 22, 2025
Citation
Yang, Michelle. "Selegiline." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787537/6.2/Selegiline.
Yang M. Selegiline. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787537/6.2/Selegiline. Accessed November 4, 2025.
Yang, M. (2025). Selegiline. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787537/6.2/Selegiline
Yang M. Selegiline [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 November 04]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787537/6.2/Selegiline.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selegiline
ID - 787537
A1 - Yang,Michelle,Pharm.D., BCPP
Y1 - 2025/09/22/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787537/6.2/Selegiline
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
